将O型心脏与非O型受者共享的影响:基于器官共享联合网络登记处的模拟研究
本研究基于2008至2015年器官共享联合网络登记处成人心脏移植候选者数据,经倾向性匹配纳入8187例O型与非O型候选者,比较等待期死亡与移植累积发生率及移植后生存,并用四状态马尔可夫模型模拟分配策略变化对生存的影响。结果显示O型候选者移植率更低、等待期死亡率更高;模拟将非O型受者接受O型心脏的比例从当前19%降至5%可使O型与非O型移植后生存相近。
要点
- O型候选者移植累积发生率低于非O型(p<0.001),等待期死亡显著更高(p<0.001)。
- 中位随访2.1年,非O型移植69.6% vs O型54.9%(p<0.001)。
- 模拟将非O型受者接受O型心脏比例从19%降至5%可使O型与非O型移植后生存相近。
核心结论
- 现行策略下O型与非O型候选者存在死亡与移植率差异,基于模拟的分配策略可能有助于减轻血型间差异。
研究设计与样本
- 回顾性分析器官共享联合网络登记处2008至2015年成人心脏移植候选者,经倾向性匹配纳入8187例O型与非O型候选者。
- 构建四状态马尔可夫模型(无左心室辅助装置等待、带左心室辅助装置等待、移植、死亡)模拟 listing 后生存,并进行敏感性分析。
主要发现
- O型候选者移植累积发生率低于非O型(p<0.001),等待期死亡显著更高(p<0.001)。
- 中位随访2.1年,非O型候选者移植69.6% vs O型54.9%(p<0.001)。
- 19%的非O型受者接受了O型心脏。
- 模拟显示将非O型受者接受O型心脏比例从当前19%降至5%可使O型与非O型移植后生存相近。
关键数值与推荐
- 倾向性匹配后纳入8187例O型与非O型候选者。
- O型移植累积发生率低于非O型(p<0.001),等待期死亡显著更高(p<0.001)。
- 中位随访2.1年,非O型移植69.6% vs O型54.9%(p<0.001)。
- 19%的非O型受者接受了O型心脏。
- 模拟将非O型受者接受O型心脏比例从19%降至5%可使O型与非O型生存相近。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Blood type O heart transplant recipients wait longer than non-O recipients and frequently require bridging left ventricular assist devices (LVADs). However, rarely has the effect of this disparity been shown in a large registry. This study used Markov simulation to clarify the outcome difference between O and non-O candidates and how allocation change could affect survival. METHODS: We reviewed the United Network for Organ Sharing registry for adults listed for heart transplantation from 2008 to 2015. Cumulative incidences of death or transplant and survival after listing were compared between O and non-O using propensity matching. A four-state Markov model-waiting without LVAD, waiting with LVAD, transplantation, and death-was created to simulate survival after listing. Sensitivity analysis was performed to see how the percentage of O hearts in non-O recipients would affect survivals. RESULTS: A total of 8,187 O and non-O candidates were included after matching. The cumulative incidence of transplantation was lower in O (p < 0.001), and death after listing was significantly higher (p < 0.001). During a median follow-up of 2.1 years, 69.6% of non-O candidates were transplanted, compared with 54.9% of O candidates (p < 0.001). Despite this disparity, 19% of non-O recipients received O hearts. Our simulated survival demonstrated that decreasing the O heart percentage in non-O recipients from the current 19% to 5% would provide similar survival in O and non-O after listing. CONCLUSIONS: Under the current strategy, there are death and transplant rate differences between O and non-O candidates. Our simulation-based allocation strategy might aid in mitigating this discrepancy across blood types.
引用
- Ando M, Takeda K, Kurlansky PA, et al. Impact of Sharing O Heart With Non-O Recipients: Simulation in the United Network for Organ Sharing Registry. Ann Thorac Surg. 2018. PMID: 30076793. doi:10.1016/j.athoracsur.2018.06.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。